LGL Leukemia
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL (NCT03239392) | Bioniz Therapeutics | 2018-04-01 |
| Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia (NCT00363779) | National Cancer Institute (NCI) | 2006-06-01 |
Track LGL Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.